Lovastatin Tablet
Product Images NDC 68788-8326

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 68788-8326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lovastatin Tablets Usp 20mg Lupin (22c9f2d8 7bcd 4415 Bbc8 505720033966 00)

FDA Label Image

Lovastatin (65abb8c3 847f 4fb3 B8de 21888c01210b 01)

FDA Label Image

Figure 1 (65abb8c3 847f 4fb3 B8de 21888c01210b 02)

Figure 1 (65abb8c3 847f 4fb3 B8de 21888c01210b 02)
The text is a graph with a title "Proportion of Participants Without Event" and a sub-title "Acute Major Coronary Events (Primary Endpoint)". It shows a figure denoting years of follow-up and a risk reduction percentage of 87%. The graph has two data points marked 0.94 and 0.92. Therefore, it represents a study result of a risk reduction in acute major coronary events over the years of follow-up.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.